Drug · DIN 02530295
RYMTI
1 ML SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 5, 2024; first marketed April 5, 2024.
- Drug Identification Number (DIN)
- 02530295
- Company (DIN owner)
- Lupin Pharma Canada LimitedLongueuil, Quebec, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Etanercept L04AB01
- Class
- Human
- Record last updated
- August 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ETANERCEPT | 50 MG | 1 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 31, 2022: NOC 28898New Drug Submission (NDS)
Other DINs named RYMTI
- DIN 02530309 · Marketed
- DIN 02530287 · Approved